Investment Type: Venture Capital
Investment Stage: Series A
Portfolio 2
| Date | Name | Website | Total Raised | Location |
| 10.08.2025 | Minghui Ph... | minghuipharma.com | $131M | China |
| 15.12.2021 | Cargene Th... | cargene.com | $19.2M | Singapore |
Mentions in press and media 6
| Date | Title | Description |
| 08.09.2025 | Rapafusyn Pharmaceuticals Closes $44M Series A Financing | Rapafusyn Pharmaceuticals, a Baltimore, MD-based company which specializes in the discovery and development of non-degrading molecular glue therapeutics, raised $44M in Series A funding. The round was led by BioTrack Capital and Yonjin Capi... |
| 11.08.2025 | Minghui Pharmaceutical Raises USD 131M in Pre-IPO Financing | Minghui Pharmaceutical, a Singapore-based clinical biopharmaceutical company, raised USD 131M Pre-IPO financing. The round was led by new investors OrbiMed and co-led by Qiming Venture Partners with participation from existing investor TF C... |
| 10.08.2025 | OrbiMed, Qiming lead $131m pre-IPO financing for late-stage clinical biopharma Minghui | Global healthcare investment firm OrbiMed and Qiming Venture Partners have jointly led a pre-IPO financing of $131 million in Minghui Pharmaceutical, a Chinese late-stage clinical biopharmaceutical company, according to a statement. Shangha... |
| 07.08.2025 | Minghui Pharmaceutical Announces USD 131 Million Pre-IPO Financing to Advance Late-Stage Pipeline and Global Expansion | SHANGHAI, Aug. 7, 2025 /PRNewswire/ -- Minghui Pharmaceutical ("Minghui"), a late-stage clinical biopharmaceutical company, today announced the closing of a USD 131 million Pre-IPO financing led by new investors OrbiMed and co-led... |
| 14.12.2021 | Cargene Closes a US$19.2M Pre-A Round Led by BioTrack Capital | SINGAPORE and SHANGHAI and BOSTON, Dec. 14, 2021 /PRNewswire/ -- Cargene Biopharma Inc. ("Cargene") announced today the close of an over-subscribed US$19.2 million pre-Series A funding round. The financing was led by BioTrack Capi... |
| 14.12.2021 | Cargene Closes a US$19.2M Pre-A Round Led by BioTrack Capital | SINGAPORE and SHANGHAI and BOSTON, Dec. 14, 2021 /PRNewswire/ -- Cargene Biopharma Inc. ("Cargene") announced today the close of an over-subscribed US$19.2 million pre-Series A funding round. The financing was led by BioTrack Capi... |